Qure.ai

About

Qure.ai is a healthcare technology company founded in 2016, based in Mumbai, India. It specializes in leveraging artificial intelligence (AI) to enhance medical imaging analysis for disease detection and diagnosis. The company's primary focus is on developing AI-powered tools for interpreting radiology exams and ultrasound scans, aiming to improve the speed and accuracy of diagnostic processes. Qure.ai's solutions are designed to assist healthcare professionals in diagnosing conditions such as lung nodules, strokes, and heart failure. Qure.ai's flagship product, qXR, is a CE-certified software that can detect up to 30 findings on chest X-rays, including early signs of lung cancer and heart failure. The company's technology is built on deep learning models and convolutional neural networks, allowing for continuous learning and explainable AI. Qure.ai has a significant presence in the global healthcare AI market, with its solutions deployed at over 2,700 imaging sites across more than 90 countries. The company has secured substantial funding to expand its AI innovations and market reach, particularly into the US.